
-
Israel's Netanyahu warns wildfires could reach Jerusalem
-
Istanbul lockdown aims to prevent May Day marches
-
Australian guard Daniels of Hawks named NBA's most improved
-
Mexico City to host F1 races until 2028
-
Morales vows no surrender in bid to reclaim Bolivian presidency
-
Ukraine, US sign minerals deal, tying Trump to Kyiv
-
Phenomenons like Yamal born every 50 years: Inter's Inzaghi
-
Ukraine, US say minerals deal ready as Kyiv hails sharing
-
Global stocks mostly rise following mixed economic data
-
O'Sullivan says he must play better to win eighth snooker world title after seeing off Si Jiahui
-
Sabalenka eases past Kostyuk into Madrid Open semis
-
Netflix's 'The Eternaut' echoes fight against tyranny: actor Ricardo Darin
-
US economy unexpectedly shrinks, Trump blames Biden
-
Barca fight back against Inter in sensational semi-final draw
-
Meta quarterly profit climbs despite big cloud spending
-
US Supreme Court weighs public funding of religious charter school
-
Climate change made fire conditions twice as likely in South Korea blazes: study
-
Amorim says not even Europa League glory can save Man Utd's season
-
Syria reports Israeli strikes as clashes with Druze spread
-
Ukraine, US say minerals deal ready as suspense lingers
-
Everything is fine: Trump's cabinet shrugs off shrinking economy
-
Chelsea boss Maresca adamant money no guarantee of success
-
Wood warns England cricketers against 'dumb' public comments
-
US economy shrinks, Trump blames Biden
-
Caterpillar so far not hiking prices to offset tariff hit
-
Japan's Kawasaki down Ronaldo's Al Nassr to reach Asian Champions League final
-
Trump praises Musk as chief disruptor eyes exit
-
Chahal hat-trick helps Punjab eliminate Chennai from IPL playoff race
-
Pope Francis saw clergy's lack of humility as a 'cancer': author
-
Weinstein accuser recounts alleged rape at assault retrial in NY
-
Piastri heads into Miami GP as the man to beat
-
US economy unexpectedly shrinks in first quarter, Trump blames Biden
-
Maxwell likely to miss rest of IPL with 'fractured finger'
-
Syria reports Israeli strikes after warning over Druze as sectarian clashes spread
-
Despite war's end, Afghanistan remains deep in crisis: UN relief chief
-
NFL fines Falcons and assistant coach over Sanders prank call
-
British teen Brennan takes stage 1 of Tour de Romandie
-
Swedish reporter gets suspended term over Erdogan insult
-
Renewable energy in the dock in Spain after blackout
-
South Africa sets up inquiry into slow apartheid justice
-
Stocks retreat as US GDP slumps rattles confidence
-
Migrants' dreams buried under rubble after deadly strike on Yemen centre
-
Trump blames Biden's record after US economy shrinks
-
UK scientists fear insect loss as car bug splats fall
-
Mexico avoids recession despite tariff uncertainty
-
Rwandan awarded for saving grey crowned cranes
-
Spurs have 'unbelievable opportunity' for European glory: Postecoglou
-
Microsoft president urges fast 'resolution' of transatlantic trade tensions
-
Poppies flourish at Tower of London for WWII anniversary
-
US economy unexpectedly shrinks on import surge before Trump tariffs

The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
L.Dubois--BTB